Evidence map›Paper›PMID 30237126›Full record

ArticleRedox biology2018

Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.

Yan Jia, Feixia Wang, Qin Guo, Mengmeng Li, Ling Wang, Zili Zhang, Shuoyi Jiang, Huanhuan Jin, Anping Chen, Shanzhong Tan and 3 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 149 citations in OpenAlex.

  1. Review
  2. Article
  3. [Research progress on cellular senescence and liver diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. The role of JNK signaling pathway in organ fibrosis.Journal of advanced research · 2025
    Review
  8. Chinese herbal medicines · 2025
    Review
  9. Article
  10. Review
  11. Curcuminoids as natural modulators of necroptosis: therapeutic implications.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Yan JiaDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Feixia WangDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Qin GuoDermatology of Jiangsu Province Hospital of TCM, China.
Mengmeng LiDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Ling WangDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Zili ZhangDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Shuoyi JiangDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Huanhuan JinDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Anping ChenDepartment of Pathology, School of Medicine, Saint Louis University, St Louis, MO 63104, USA.
Shanzhong TanDepartment of Hepatology, Integrated Traditional Chinese and Western Medicine, Nanjing Second Hospital, China.
Feng ZhangDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Jiangjuan ShaoDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. Electronic address: jjshao1976@163.com.
Shizhong ZhengDepartment of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Key Laboratory of Therapeutic Material of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. Electronic address: nytws@163.com.
Nanjing University of Chinese Medicine · CNJiangsu Province Hospital · CNNanjing Second Hospital · CNSaint Louis University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is generally recognized that hepatic fibrogenesis is an end result of increased extracellular matrix (ECM) production from the activation and proliferation of hepatic stellate cells (HSCs). An in-depth understanding of the mechanisms of HSC necroptosis might provide a new therapeutic strategy for prevention and treatment of hepatic fibrosis. In this study, we attempted to investigate the effect of curcumol on necroptosis in HSCs, and further to explore the molecular mechanisms. We found that curcumol ameliorated the carbon tetrachloride (CCl

Indexed as

AcetylcysteineAnimalsCarbon TetrachlorideCell ProliferationCells, CulturedHepatic Stellate CellsLiver CirrhosisMaleMiceMice, Inbred ICRMitochondriaMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9NecrosisPhosphorylationRandom AllocationAcetylcysteineCarbon TetrachloridecurcumolMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9Reactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouseRipk3 protein, mouseRNA, Small InterferingSesquiterpenesCurcumolHepatic stellate cellLiver fibrosisNecroptosisReceptor-interacting protein kinaseROS

Identifiers

PMID30237126
PMCPMC6142373
OpenAlexW2890663000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.